The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Mammalian Tumor Xenografts Induce Neovascularization in Zebrafish Embryos
Open accessAbstract
The zebrafish (Danio rerio)/tumor xenograft model represents a powerful new model system in cancer. Here, we describe a novel exploitation of the zebrafish model to investigate tumor angiogenesis, a pivotal step in cancer progression and target for antitumor therapies. Human and murine tumor cell lines that express the angiogenic fibroblast growth factor (FGF) 2 and/or vascular endothelial growth factor (VEGF) induce the rapid formation of a new microvasculature when grafted close to the developing subintestinal vessels of zebrafish embryos at 48 h postfertilization. Instead, no angiogenic response was exerted by related cell clones defective in the production of these angiogenic growth factors. The newly formed blood vessels sprout from the subintestinal plexus of the zebrafish embryo, penetrate the tumor graft, and express the transcripts for the zebrafish orthologues of the early endothelial markers Fli-1, VEGF receptor-2 (VEGFR2/KDR), and VE-cadherin. Accordingly, green fluorescent protein–positive neovessels infiltrate the graft when tumor cells are injected in transgenic VEGFR2:G-RCFP zebrafish embryos that express green fluorescent protein under the control of the VEGFR2/KDR promoter. Systemic exposure of zebrafish embryos immediately after tumor cell injection to prototypic antiangiogenic inhibitors, including the FGF receptor tyrosine kinase inhibitor SU5402 and the VEGFR2/KDR tyrosine kinase inhibitor SU5416, suppresses tumor-induced angiogenesis without affecting normal blood vessel development. Accordingly, VE-cadherin gene inactivation by antisense morpholino oligonucleotide injection inhibits tumor neovascularization without affecting the development of intersegmental and subintestinal vessels. These data show that the zebrafish/tumor xenograft model represents a novel tool for investigating the neovascularization process exploitable for drug discovery and gene targeting in tumor angiogenesis. [Cancer Res 2007;67(7):2927–31]
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Effective targeted gene ‘knockdown’ in zebrafish
Nasevicius, A., & Ekker, S. C. (2000) · Nature Genetics · doi:10.1038/79951 · Cited by 2,483
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
Presta, M., Dell’Era, P., Mitola, S., Moroni, E., Ronca, R., & Rusnati, M. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.004 · Cited by 1,261
Self-citationEmbryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness
Topczewska, J. M., Postovit, L.-M., Margaryan, N. V., Sam, A., Hess, A. R., Wheaton, W. W., Nickoloff, B. J., Topczewski, J., & Hendrix, M. J. C. (2006) · Nature Medicine · doi:10.1038/nm1448 · Cited by 438
Lam, S. H., Wu, Y. L., Vega, V. B., Miller, L. D., Spitsbergen, J., Tong, Y., Zhan, H., Govindarajan, K. R., Lee, S., Mathavan, S., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1169 · Cited by 289
Zebrafish angiogenesis: A new model for drug screening
Serbedzija, G. N., Flynn, E., & Willett, C. E. (1999) · Angiogenesis · doi:10.1023/a:1026598300052 · Cited by 272
Brown, L. A., Rodaway, A. R. F., Schilling, T. F., Jowett, T., Ingham, P. W., Patient, R. K., & Sharrocks, A. D. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00256-7 · Cited by 260
Organogenesis--Heart and Blood Formation from the Zebrafish Point of View
Thisse, C., & Zon, L. I. (2002) · Science · doi:10.1126/science.1063654 · Cited by 235
Analysis of a Zebrafish VEGF Receptor Mutant Reveals Specific Disruption of Angiogenesis
Habeck, H., Odenthal, J., Walderich, B., Maischein, H.-M., & Schulte-Merker, S. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01044-8 · Cited by 229
Cited by
Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials
Patton, E. E., Zon, L. I., & Langenau, D. M. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00210-8 · Cited by 567
Hooked! Modeling human disease in zebrafish
Santoriello, C., & Zon, L. I. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60434 · Cited by 513
MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis
Nicoli, S., Standley, C., Walker, P., Hurlstone, A., Fogarty, K. E., & Lawson, N. D. (2010) · Nature · doi:10.1038/nature08889 · Cited by 442
Self-citationCoordinating cell behaviour during blood vessel formation
Geudens, I., & Gerhardt, H. (2011) · Development · doi:10.1242/dev.062323 · Cited by 376
Visualizing extravasation dynamics of metastatic tumor cells
Stoletov, K., Kato, H., Zardouzian, E., Kelber, J., Yang, J., Shattil, S., & Klemke, R. (2010) · Journal of Cell Science · doi:10.1242/jcs.069443 · Cited by 333
Metadata
- Authors
- Nicoli, S., Ribatti, D., Cotelli, F., & Presta, M.
- Venue
- Cancer Research
- Published
- 2007-04-01
- Volume
- 67
- Issue
- 7
- Pages
- 2927-2931
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2099345094
- Cited by
- 276
- References
- 18
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mammalian Tumor Xenografts Induce Neovascularization in Zebrafish Embryos. https://app.cochat.ai/papers/10.1158/0008-5472.can-06-4268
- The paper
- Nicoli, S., Ribatti, D., Cotelli, F., & Presta, M. (2007). Mammalian Tumor Xenografts Induce Neovascularization in Zebrafish Embryos. Cancer Research. https://doi.org/10.1158/0008-5472.can-06-4268
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.